摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3',5'-bis-O-[dimethyl(1,1,2-trimethylpropyl)silyl]thymidine | 123533-03-9

中文名称
——
中文别名
——
英文名称
3',5'-bis-O-[dimethyl(1,1,2-trimethylpropyl)silyl]thymidine
英文别名
3',5'-bis-O-(dimethylthexylsilyl)thymidine;3',5'-bis-O-thexyldimethylsilylthymidine;1-[(2R,4S,5R)-4-[2,3-dimethylbutan-2-yl(dimethyl)silyl]oxy-5-[[2,3-dimethylbutan-2-yl(dimethyl)silyl]oxymethyl]oxolan-2-yl]-5-methylpyrimidine-2,4-dione
3',5'-bis-O-[dimethyl(1,1,2-trimethylpropyl)silyl]thymidine化学式
CAS
123533-03-9
化学式
C26H50N2O5Si2
mdl
——
分子量
526.864
InChiKey
KEXLABIQNCPOHS-BHDDXSALSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.82
  • 重原子数:
    35
  • 可旋转键数:
    10
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.85
  • 拓扑面积:
    77.1
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis of 3′-substituted-2′,3′-dideoxynucleoside analogs as potential anti-aids drugs
    作者:Michel Maillard、Abdesslem Faraj、François Frappier、Jean-Claude Florent、David S. Grierson、Claude Monneret
    DOI:10.1016/s0040-4039(00)99623-0
    日期:1989.1
    3′-Amino-3′-deoxythymidine was prepared in six steps and in 67% overall yield from thymidine. Five derivatives of and compound were tested for their anti-HIV activity.
    3'-氨基-3'-脱氧胸苷分六个步骤制备,胸腺嘧啶核苷的总收率为67%。五个衍生品和复合他们的抗HIV活性进行了测试。
  • Nucleotides, Part LXV, Synthesis of 2′-Deoxyribonucleoside 5′-Phosphoramidites: New Building Blocks for the Inverse (5′-3′)-Oligonucleotide Approach
    作者:Thomas Wagner、Wolfgang Pfleiderer
    DOI:10.1002/1522-2675(20000809)83:8<2023::aid-hlca2023>3.0.co;2-p
    日期:2000.8.9
    The syntheses of the 3'-O-(4,4'-dimethoxytrityl)-protected 5'-phosphoramidites 25-28 and 5'-(hydrogen succinates) 29-32, which can be used as monomeric building blocks for the inverse (5'-3')-oligodeoxyribonucleotide synthesis are described (Scheme). These activated nucleosides and nucleotides were obtained by two slightly different four-step syntheses starting with the base-protected nucleosides 13-20. For the protection of the aglycon residues, the well-established 2-(4-nitrophenyl)ethyl (npe) and [2-(4-nitrophenyl)ethoxy]carbonyl (npeoc) groups were used. The assembly of the oligonucleotides required a slightly increased coupling time of 3 min in application of the common protocol (see Table 1). The use of pyridinium hydrochloride as an activator (instead of 1H-tetrazole) resulted in an extremely shorter activation time of 30 seconds. We established the efficiency of this inverse strategy by the synthesis of the oligonucleotide 3'-conjugates 33 and 34 which carry lipophilic caps derived from cholesterol and vitamin E, respectively, as well as by the formation of (3'-3')- and (5'-5')-internucleotide linkages (see Table 2).
  • An Inverse Approach in Oligodeoxyribonucleotide Synthesis
    作者:Thomas Wagner、Wolfgang Pfleiderer
    DOI:10.1080/07328319708006249
    日期:1997.7
    We synthesized 3'-O-dimethoxytrityl-5'O-phosphoramidites and 5'-O-succinates which can be used as monomeric building blocks for the built up of oligodeoxyribonucleotides in the alternative 5'-3' direction. With this inverse strategy oligonucleotide 3'-conjugates as well as 3'-3' and 5'-5' internucleotidic linkages can be easily formed.
  • 1,3-DIPOLAR CYCLOADDITION REACTIONS OF 3′,5′-<i>BIS</i>-<i>O</i>-SILYL THYMIDINES. SYNTHESIS OF NOVEL AZABICYCLIC COMPOUNDS
    作者:G. Negrón、G. Calderón、F. Vázquez、L. Lomas、J. Cárdenas、C. Márquez、R. Gaviño
    DOI:10.1081/scc-120004847
    日期:2002.1
    An efficient one step procedure for the preparation of (4.3.0) bicyclic N-methylpyrrolidine thymidine derivatives 4, using cycloaddition reaction of the highly reactive non-stabilized azomethine ylide [Y] with 3',5'-Bis-O-silylthymidines 3.
  • MAILLARD, MICHEL;FARAJ, ABDESSLEM;FRAPPIER, FRANCOIS;FLORENT, JEAN-CLAUDE+, TETRAHEDRON LETT., 30,(1989) N5, C. 1955-1958
    作者:MAILLARD, MICHEL、FARAJ, ABDESSLEM、FRAPPIER, FRANCOIS、FLORENT, JEAN-CLAUDE+
    DOI:——
    日期:——
查看更多